Pyxis Oncology, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Pyxis Oncology, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
  • Pyxis Oncology, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 60.5M shares, a 57.6% increase year-over-year.
  • Pyxis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 39.9M shares, a 20.8% increase from 2022.
  • Pyxis Oncology, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 33M shares, a 289% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 60.5M +22.1M +57.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 51.3M +15.9M +45.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 39.9M +6.87M +20.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 41.3M +8.77M +26.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 38.4M +5.94M +18.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 35.4M +3.03M +9.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 33M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 32.6M +31M +1959% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 32.5M +31M +2105% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 32.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 1.58M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 1.47M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.